The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: A focus on health economics

Medicine & Life Sciences

• Isophane Insulin 100%
• Insulin Glargine 94%
• Cost-Benefit Analysis 58%
• Diabetes Mellitus 53%
• Economics 52%
• Type 2 Diabetes Mellitus 50%
• Quality-Adjusted Life Years 37%
• Marketing 36%
• Life Expectancy 33%
• Global Health 33%
• Health 33%
• Health Care Costs 30%
• Public Health 24%
• Pressure 21%
• Quality of Life 21%
• Costs and Cost Analysis 21%
• Eye 20%
• Kidney 18%